EMEA Head of Portfolio Strategy

InMarket Portfolio Maximization

• • Analyzing the current Santen portfolio to develop and implement portfolio strategies aligned with the companys business goals and market trends in the EMEA region with a midlongterm view to maximize revenue growth and market share while optimizing profits. Doing so requires close crossfunctional collaboration primarily with the Marketing department as any plan/strategy needs to be dovetailed with the Therapeutic Area Plans developed by the Marketing Directors.
  • Financial Analysis: Monitor financial performance of the portfolio analyze key metrics such as revenue profitability and return on investment and make recommendations for resource allocation and investment decisions. There is also a need to develop and manage a budget including identifying opportunities for savings and efficiencies.
  • Product Lifecycle Management: Oversee the entire lifecycle of products in the portfolio from development and launch to maturity and phaseout ensuring optimal resource allocation and portfolio optimization.
  • Portfolio optimization including portfolio rationalization and divestment of nonpriority assets to focus resources for new products addressing high unmet needs with greater potential.   

Future Portfolio Development

• • Strategic Planning: Collaborate with crossfunctional teams to develop longterm strategic plans that inform and direct portfolio diversification expansion into new market segments and strategic partnerships or acquisitions.
  • Market Analysis: Conduct comprehensive market analyses to identify priority market segments where the strategic fit with Santen and the unmet need are high assess competition and make datadriven decisions about portfolio priorities.
  • Market intelligence & Trends: Stay on top of industry trends market dynamics competitors activities and emerging technologies to identify growth opportunities and threats.
  • Innovation and Pipeline Development: Drive innovation by evaluating new product opportunities supporting R&D initiatives and managing the pipeline to ensure a robust portfolio of products. To do so build deep customer patient and disease insights by conducting primary and secondary research taking opportunities to learn at congresses and by working closely with the EMEA market research and medical affairs teams to identify potential new opportunities.
  • Risk Management: Identify and mitigate risks related to portfolio decisions such as regulatory challenges market shifts or competitive threats.
  • Develop business cases and support duediligence by developing robust forecasts scenario analysis and gotomarket models based on solid data from strong market and customer understanding. This requires strong collaboration with marketing country organizations business development and finance.

New Products Commercial Development

• • Developing robust market understanding for early new products (earlier than 2436 from launch) e.g. patient journey stakeholder mapping etc.
  • Early integrated product strategy: work closely with a crossfunctional team including marketing (if the therapy area expertise exists) access medical and regulatory to develop an integrated product strategy including positioning evidence generation pricing strategies and gotomarket plans.
  • Implement asset and market shaping strategies required at this early stage to secure the fulfilment of the strategic imperatives of the product strategy. This includes risk management.
  • Lead or colead product commercialization plans with launch program management and the relevant functions like development regulatory manufacturing and supply chain.

• Stakeholder Engagement: Engage with internal stakeholders (e.g. senior management R&D teams marketing teams medical affairs market access etc.) and external stakeholders (e.g. regulatory authorities key opinion leaders industry partners payers) to align strategies and ensure successful execution. This role will require in particular close collaboration with global corporate and portfolio strategy as well as EMEA and global business development.

• Compliance and Ethics: Ensure that all portfolio strategies and activities comply with regulatory requirements industry standards and ethical guidelines.

Qualifications :

• At least 10 years of experience working in a pharmaceutical or biotechnology industry with a focus on strategic planning portfolio management product development or related areas.
• Experience specifically in the EMEA region is highly valued due to the regions unique market dynamics and regulatory environment.
• Ideally will have worked on various brands at different stages of lifecycle i.e. prelaunch planning life cycle management.
• Experience of commissioning regional or global market research projects and developing long term disease/brand sales forecasts.
• Demonstrated ability to work independently and proactively. 
• Demonstrated leadership skills in developing and implementing strategic plans driving portfolio optimization and aligning business objectives with market opportunities. Experience in leading crossfunctional teams and managing complex projects. 
• A deep understanding of regulatory requirements and compliance standards in the pharmaceutical industry especially within the EMEA region. Experience navigating regulatory challenges and ensuring compliance in portfolio strategies is important. 
• Proficiency in financial analysis budgeting and resource allocation. Experience in evaluating investment opportunities assessing ROI and managing financial performance within a portfolio context. 
• Proven ability to build and maintain relationships with key stakeholders including senior management regulatory authorities healthcare professionals and industry partners. Strong communication negotiation and influencing skills are essential. 
• Ability to motivate and work well with diverse global and crossfunctional teams. 
• Excellent oral and written communications skills. 
• Creative thinking to find innovative business solutions

Remote Work :

Yes

Employment Type :

Fulltime